Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | GGT1 | P19440 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL20479433 | 0.87 | CYP1A2 (0.39) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL5608580 | 0.85 | CYP1A2 (0.38) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL5608578 | 0.85 | CYP1A2 (0.38) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 | |
| Pivalate SCHEMBL1831112 | 0.84 | CYP2D6 (0.40) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 | |
| Oxalic Acid SCHEMBL27763558 | 0.81 | CYP1A2 (0.37) | CYP1A2CYP2D6ALDH1A1TSHRARG1 | |
| Bicarbonate SCHEMBL28262249 | 0.81 | CYP1A2 (0.37) | CYP1A2CYP2D6ALDH1A1TSHRARG1 | |
| Acetic Acid SCHEMBL1033678 | 0.81 | FFAR3 (0.41) | CYP1A2CYP2D6ALDH1A1TSHRARG1 | |
| Trifluoroacetic Acid SCHEMBL2267588 | 0.81 | ALDH1A1 (0.44) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL3416090 | 0.78 | SLC7A5 (0.41) | ALDH1A1TSHRDPP8DPP7DPP4 | |
| Trifluoroacetic Acid SCHEMBL7440809 | 0.78 | ALDH1A1 (0.42) | CYP1A2CYP2D6NOS1NOS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7217814-B2 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. (US) | 2007-05-15 | — | — | US | disclosed |
| CN-1290825-C | Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds | AVENTIS PHARMA GMBH (DE) | 2006-12-20 | — | — | CN | disclosed |
| CN-1237052-C | Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors | AVENTIS PHARMA GMBH (DE) | 2006-01-18 | — | — | CN | disclosed |
| US-20050124804-A1 | Methods of producing phosphitylated compounds | WERNER CHRISTIAN (DE) | 2005-06-09 | — | — | US | disclosed |
| US-6894158-B2 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. (US) | 2005-05-17 | — | — | US | disclosed |
| EP-1476407-A2 | METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS | Honeywell International Inc. (US) | 2004-11-17 | — | — | EP | disclosed |
| CN-1537102-A | Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors | ���ĵ�˹ҩ��¹�����˾ | 2004-10-13 | — | — | CN | disclosed |
| CN-1494527-A | Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds | ���ĵ�˹ҩ��¹�����˾ | 2004-05-05 | — | — | CN | disclosed |
| US-20030232980-A1 | Methods of producing phosphitylated compounds | HONEYWELL INTERNATIONAL INC. | 2003-12-18 | — | — | US | disclosed |
| WO-2003072586-A2 | METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS | HONEYWELL INTERNATIONAL INC. (US) | 2003-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124804-A1 | Methods of producing phosphitylated compounds | PHOSPHO1, INPPL1, PLCB3 | CYP1A2 4053/4885CYP2D6 3199/4885NOS1 4725/4885 |
| US-20030232980-A1 | Methods of producing phosphitylated compounds | PHOSPHO1, INPPL1, PLCG1 | CYP1A2 4191/4885CYP2D6 3172/4885NOS1 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.